Back to Journals » Therapeutics and Clinical Risk Management » Volume 9

Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations

Total article views   HTML views PDF downloads Totals
8,924 Dovepress* 7,344+ 1,920 9,264
PubMed Central* 1,580 380 1,960
Totals 8,924 2,300 11,224
*Since 25 November 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar